PharmaDrug Initiates Preclinical Study of Cepharanthine to B

PharmaDrug” or the “
Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that it has entered into a service agreement with a respected contract research organization (CRO) with deep expertise in preclinical oncology model development and drug testing, to evaluate the Company’s patented enteric-coated formulation of Cepharanthine (“PD-001”) in a broad panel of human cancers.
We apologize, but this video has failed to load.
Try refreshing your browser.
PharmaDrug Initiates Preclinical Study of Cepharanthine to Both Broaden Its Cancer Scope and to Streamline Its Strategy for Esophageal Cancer Back to video

Related Keywords

Germany , Japan , United States , Netherlands , Chikita , Fukui , Canada , Toronto , Ontario , Canadian , German , Dutch , Liy Pleiotropic , Wangy Cepharanthine , Daniel Cohen , Nemesb Hemorheological , Clin Hemorheol Microcirc , Newsfile Corp , Schedulei European Union , Pharmadrug Inc , Pharmadrug Initiates Preclinical Study , Both Broaden Its Cancer Scope , Streamline Its Strategy , Esophageal Cancer , Orphan Drug Designation , Enteric Coated Cepharanthine , Pharmadrug Production Gmbh , Super Smart , Sairiyo Therapeutics , Regarding Forward Looking Information , Intj Mol , ஜெர்மனி , ஜப்பான் , ஒன்றுபட்டது மாநிலங்களில் , நெதர்லாந்து , ஃப்யூக்யூயீ , கனடா , டொராண்டோ , ஆஂடேரியொ , கனடியன் , ஜெர்மன் , டச்சு , டேனியல் கோஹன் , உணவுக்குழாய் புற்றுநோய் , ஆர்ஃபந் மருந்து பதவி , அருமை புத்திசாலி , தொடர்பாக முன்னோக்கி பார்க்கிறது தகவல் ,